Affordable Access

Current state of treatment for primary cutaneous melanoma

Authors
Journal
Clinical and Experimental Medicine
1591-8890
Publisher
Springer-Verlag
Publication Date
Disciplines
  • Biology
  • Design
  • Education
  • Medicine

Abstract

The incidence of malignant melanoma has been rising steadily for the last 30 years. Through physician and patient education, surveillance of high-risk individuals, and biopsy of any suspicious lesions, more lesions are being diagnosed earlier, where there is a high cure rate. Unfortunately many patients will still present with thicker lesions or nodal involvement, which carries a significantly worse prognosis. Over the past decade, there have been several changes in the management of primary cutaneous melanoma. These have stemmed from novel surgical approaches, a new understanding of melanoma biology, and randomized clinical trials designed to improve outcome and decrease the morbidity of therapy. This article will review the clinical evidence behind the current treatment recommendations for primary cutaneous melanoma as well as some of the emerging data on innovative immunologic-approaches to melanoma treatment.

There are no comments yet on this publication. Be the first to share your thoughts.

Statistics

Seen <100 times
0 Comments

More articles like this

Current state of treatment for primary cutaneous m...

on Clinical and experimental medi... October 2004

Malignant melanoma: current state of primary and a...

on Critical Reviews in Oncology/H... Jan 01, 2003

Malignant melanoma: current state of primary and a...

on Critical Reviews in Oncology/H... March 2003
More articles like this..